Kirsten Axelsen on Healthcare Reform

DLA Piper

+ Follow Contact

Latest Posts › Healthcare Reform

Share:

Keeping Watch on Medicare: Formulary Assessment Shows Large Declines in Access for Certain Rare Disease Treatments

The Inflation Reduction Act (IRA) changed how drugs are covered and reimbursed in Medicare. It is anticipated that this may lead to more restrictive formularies in drug plans....more

7/30/2025 / Drug Pricing , Health Insurance , Healthcare Reform , Inflation Reduction Act (IRA) , Medicare , Pharmaceutical Industry , Prescription Drugs

Keeping Watch on the IRA: Co-pays Increasing for Diabetes Medications

The Inflation Reduction Act (IRA) made changes to the way drugs are covered and reimbursed in Medicare. It has been anticipated that this could result in more restrictive formularies in drug plans or higher co-pays for...more

7/14/2025 / Beneficiaries , Co-payments , Drug Pricing , Healthcare Reform , Inflation Reduction Act (IRA) , Medicare , Medicare Part D , New Legislation , Prescription Drugs

Keeping Watch on the Inflation Reduction Act: Medicare Poses Part D Formulary Access Challenges

Key points include access to medicines in medicare is reduced as the IRA is implemented; fewer drugs are covered on Medicare Part D formularies in 2025 relative to 2024; medicines for serious conditions with high unmet needs...more

4/15/2025 / Centers for Medicare & Medicaid Services (CMS) , Drug Pricing , Healthcare Reform , Inflation Reduction Act (IRA) , Medicare Part D , New Regulations , Patient Access , Pharmacy Benefit Manager (PBM) , Prescription Drugs , Regulatory Oversight

Medicare Drug Price Negotiation: Saving Money for Medicare, but What About Patients?

Evaluating current formulary access for the 25 drugs selected for Drug Price Negotiation in Medicare Part D shows several selected drugs have higher co-pays in 2025 relative to 2024 - Introduction - The Inflation Reduction...more

3/31/2025 / Beneficiaries , Centers for Medicare & Medicaid Services (CMS) , Drug Pricing , Health Insurance , Healthcare Reform , Inflation Reduction Act (IRA) , Medicare , Medicare Part D , Pharmaceutical Industry , Prescription Drugs

4 Results

View per page

Page: of 1

Kirsten Axelsen